Kallieri, M. Zervas, E. Fouka, E. Porpodis, K. Mitrova, M.H. Tzortzaki, E. Makris, M. Ntakoula, M. Papaioannou, A.I. Lyberopoulos, P. Dimakou, K. Koukidou, S. Ampelioti, S. Papaporfyriou, A. Katsoulis, K. Kipourou, M. Rovina, N. Antoniou, K. Vittorakis, S. Bakakos, P. Steiropoulos, P. Markopoulou, K. Avarlis, P. Papanikolaou, Ι.C. Markatos, M. Gaki, E. Samitas, K. Glynos, K. Papiris, S.A. Papakosta, D. Tzanakis, N. Gaga, M. Kostikas, K. Loukides, S., RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response, Allergy: European Journal of Allergy and Clinical Immunology, 2022, John Wiley and Sons Inc,